Altered GABAB receptor immunoreactivity in the gerbil hippocampus induced by baclofen and phaclofen, not seizure activity

Seung Kook Park, Sung Jin An, In Koo Hwang, Dae Won Kim, Ju Young Jung, Moo Ho Won, Soo Young Choi, Oh Shin Kwon, Young Gil Jeong, Tae Cheon Kang

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

The present study was performed to determine whether the effects induced by GABAB receptor-acting drugs would be related with the alteration in GABAB receptor expression in the hippocampus using Mongolian gerbil, a genetic epilepsy model. The distribution patterns of both GABAB receptor 1A/B and GABABreceptor 2 immunoreactivities were similarly detected in the hippocampi of normal and seizure-prone gerbils. Following baclofen (GABAB receptor agonist) or phaclofen (GABAB receptor antagonist) treatment, GABAB receptor immunoreactivities were decreased or increased by dose-dependent manners, respectively. Vigabatrin (GABA transaminase inhibitor) or 3-mercaptopropionic acid (GAD inhibitor) treatment did not affect GABAB receptor expressions. These findings suggest that GABAB receptor expression in the gerbil hippocampus may be altered by baclofen or phaclofen treatment.

Original languageEnglish
Pages (from-to)405-416
Number of pages12
JournalNeuroscience Research
Volume49
Issue number4
DOIs
StatePublished - Aug 2004

Keywords

  • 3-MPA
  • Baclofen
  • Epilepsy
  • GABA receptor
  • Gerbil
  • Hippocampus
  • Phaclofen
  • Seizure
  • Vigabatrin

Fingerprint

Dive into the research topics of 'Altered GABAB receptor immunoreactivity in the gerbil hippocampus induced by baclofen and phaclofen, not seizure activity'. Together they form a unique fingerprint.

Cite this